Results 301 to 310 of about 358,941 (349)

Prediction of isocitrate dehydrogenase mutation status in WHO grade II glioma by diffusion kurtosis imaging. [PDF]

Pol J Radiol
Wu W, Zhang H.
europepmc   +1 more source

Acute myeloid leukemia treatment outcomes with isocitrate dehydrogenase mutations: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Qin H, Xu R, Yang Y.
europepmc   +1 more source

Catalytically distinct metabolic enzyme isocitrate dehydrogenase 1 mutants tune phenotype severity in tumor models. [PDF]

J Biol Chem
Schwartz AV, Chao G, Robinson M, Conley BM, Ahmed Adam MA, Wells GA, Hoang A, Albekioni E, Gallo C, Weeks J, Yunker K, Quichocho G, George UZ, Niesman I, House CD, Turcan Ş, Sohl CD.   +16 more
europepmc   +1 more source

Isocitrate Dehydrogenase 2 (IDH2)-Mutant Metastatic Esthesioneuroblastoma: A Case Report and Review of Current Therapeutic Options. [PDF]

Cureus
Banha R, Fernandes R, Floudas CS, Vieira C.   +3 more
europepmc   +1 more source

Isocitrate Dehydrogenase-Mutant WHO Grade 4 Astrocytoma with BCOR Alteration: Case Report. [PDF]

Case Rep Oncol
Kurdi M, Alkhotani A, Hafiz B, Faizo E, Okal F, Albeshri A, Najjar A, Alghefari H, Mrair F, Baeesa S.   +9 more
europepmc   +1 more source

Magnetic resonance diffusion-derived vessel density (DDVD) as a valuable tissue perfusion biomarker for isocitrate dehydrogenase genotyping in diffuse gliomas. [PDF]

BMC Med Imaging
Ni CX, Lin RL, Yao DQ, Ma FZ, Shi YT, He YY, Song Y, Yang G, Jiang RF, Wáng YXJ.   +9 more
europepmc   +1 more source

Repurposing the anthelmintic drug mebendazole in combination with radiation therapy in an isocitrate dehydrogenase mutant glioma model. [PDF]

Neurooncol Adv
Yamashita AS, da Costa Rosa M, Riggins GJ.   +2 more
europepmc   +1 more source

Natural language processing algorithms identify wild-type isocitrate dehydrogenase gliomas in electronic health records. [PDF]

Neurooncol Adv
Forrest N, Guggilla V, Bell A, Zelisko S, Federico EM, Power EA, Birch S, Nandoliya KR, Houskamp EJ, Tran S, Lukas RV, Johnson JL, Roy I, Wainwright DA, Walunas TL.   +14 more
europepmc   +1 more source

Isocitrate dehydrogenase 2 mutation promotes cytarabine resistance in acute myeloid leukemia by Warburg effect. [PDF]

Hematol Oncol
Yang J, Wang Z, Wu K, Nie B, Li L, Ruan J, Zhou Q, Zeng Y, Shi M.   +8 more
europepmc   +1 more source

Single-cell transcriptomics reveals IRF7 regulation of the tumor microenvironment in isocitrate dehydrogenase wild-type glioma. [PDF]

MedComm (2020)
Li J, Long S, Yang Z, Wei W, Yu S, Liu Q, Hui X, Li X, Wang Y.   +8 more
europepmc   +1 more source